Delivery Order SPE2DB20D3103-SPE2DB24FN9A8
- Not listed
- This federal contract award, valued at $2,114.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fosamax 70 mg tablets, a medication used to treat osteoporosis. The contract has a fixed-price delivery order structure and is set to expire on December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Fosamax 70 mg tablets. The $4,274.54 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does...
- The federal contract award summarized involves a delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,272.63 contract is for the delivery of FOSAMAX 70 MG TABLET, a medication used in the treatment of osteoporosis. This award is a Firm Fixed Price delivery order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA. The IDC...
- This federal contract award is for the supply of Fosamax 70 mg tablets to the Defense Logistics Agency (DLA). The $3,092.93 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
- This federal contract award, valued at $6,109.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fosamax 70 mg tablets, a medication used to treat osteoporosis. This is a Firm Fixed Price Delivery Order contract with a completion date of March 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $74,704.55 firm fixed-price delivery order contract is for the supply of FOSAMAX 70 MG TABLET UU 4S, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $2,612.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of FOSAMAX 70 MG TABLET, a prescription medication, with a completion date of May 8, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,215.48 firm fixed-price delivery order contract is for the delivery of Fosamax 70 mg tablets to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,833.10 firm fixed-price delivery order is for the supply of Fosamax 70 mg tablets, a medication used to treat osteoporosis. The contract has a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,898.78, is for the delivery of FOSAMAX 70 MG TABLET pharmaceutical products. It has a firm fixed price and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN9A8Delivery Order
This federal contract award, valued at $4,712.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fosamax 70 mg tablets, a medication used to treat osteoporosis. The award is a delivery order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 5/21/24 |